Skip to Content
HealthcareHealthcare
  • Article
  • Open Access

21 November 2026

14 Pages

Patients’ Attitudes Toward Deprescribing Among Adults with Chronic Diseases in Saudi Arabia

,
,
,
,
,
,
,
,
and
1
Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia
2
Department of Pharmacy Practice, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
3
College of Pharmacy, Taif University, Taif 21944, Saudi Arabia
4
College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia
Healthcare2026, 14(23), 4007;https://doi.org/10.3390/healthcare14234007 
(registering DOI)
This article belongs to the Section Chronic Care

Abstract

Background: In Saudi Arabia, chronic illnesses are one of the biggest healthcare issues. They are frequently associated with polypharmacy, which can raise the risk of medication burden and adverse drug events. The goal of deprescribing is to cut back on or stop prescription drugs that are not needed under therapeutic supervision. Understanding patients’ perspectives on deprescribing is essential to promote shared decision-making and improve medication safety. Objective: This study assessed attitudes toward deprescribing among adults with chronic diseases in Saudi Arabia. The study also examined their willingness to discontinue medications and identified demographic and clinical factors associated with personal willingness to deprescribe. Method: Analytical cross-sectional study among adults with chronic diseases in Saudi Arabia. Data were collected through an electronic survey using the validated Arabic version of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire. The study included 332 participants. Participants’ characteristics and attitudes toward deprescribing were summarized using descriptive statistics. Chi-square tests and regression analyses were then used to explore factors related to willingness to deprescribe. Results: More than half of the participants (52.4%) were willing to deprescribe medications. However, this percentage increased to 85.8% when stopping medication was recommended by their physician. In unadjusted analyses, personal willingness was significantly associated with polypharmacy, lower educational attainment, and higher numbers of chronic conditions and medications. In multivariable binary logistic regression, greater perceived medication burden (aOR = 2.51, 95% CI: 1.78–3.53) and lower educational attainment (aOR = 1.81, 95% CI: 1.04–3.12) were associated with greater personal willingness to try deprescribing. Neither the number of chronic conditions nor the number of medications was significantly associated with willingness after adjustment. Participants with polypharmacy reported greater medication burden and lower satisfaction with their medications. Participants reported high involvement in medication-related decision-making. Conclusions: Saudi adults with chronic diseases generally showed positive attitudes toward deprescribing, particularly when supported by physician recommendations. Greater perceived medication burden was consistently associated with personal willingness to deprescribe, whereas the association with educational attainment was sensitive to outcome categorization.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.